The Addition of Sufentanil Interscalene Block in Shoulder Surgery

Bent Gymoese Jorgensen26 enrolled

Overview

The purpose of this study is to compare the effects and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery.

The purpose of this study is to compare the duration of postoperative analgesia and supplemental opioid consumption and side effects of interscale block performed with Naropin 0.1% cum sufentanil or Naropin 0.1% in shoulder surgery

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE

Enrollment

Conditions

Postoperative Pain Shoulder Surgery

Interventions

Naropin 0.1% cum sufentanilDRUG

20ml of Naropin 0.1% cum sufentanil 1mikrog per ml

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ASA I-III * Age 18-80 * Shoulder surgery performed under interscalene block and general anesthesia Exclusion Criteria: * Contraindication of interscalene block * Severe chronic obstructive lung disease * Non-cooperative patient * Intolerance to opioids * Pregnancy * Rheumatoid arthritis and diabetes with peripheral polyneuropathy * Chronic pain or daily opioid intake

Locations (1)

Anesthetic Clinic, Frederiksberg University Hospital

Frederiksberg, Frederiksberg, Denmark

Outcomes

Primary Outcomes

Time to experience of moderate to severe postoperative pain

Time frame: On day of surgery and 1., 2. and 3. postop. day

Secondary Outcomes

Side effects

Time frame: On day of surgery and 1., 2. and. 3. postop. day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.